Products are for research use only, not for human use

Science

Pre-Aliquoting for Peptides: Stability, Convenience, and Workflow Efficiency

Pre-aliquoting peptides before delivery minimizes freeze-thaw cycles, preserves peptide integrity, and saves researchers time. This service is available for custom synthesis of standard peptides, peptide pools, and peptide libraries. Learn how pre-aliquoting enhances stability and streamlines laboratory workflows.

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Written by Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

July 15, 2026Updated October 12, 20265 min read

Key Takeaways

  • •Every freeze-thaw cycle is a chance to lose peptide, through ice crystal damage, pH shift as buffer components crystallise out, and concentration changes at the ice front.
  • •Pre-aliquoting means dividing the reconstituted peptide into single-use portions once, so each portion is thawed exactly one time.
  • •It is offered as a service by some custom-synthesis suppliers. Volta does not offer it: on a catalogue vial this is a procedure you run at the bench after reconstitution.
  • •Size each aliquot to one experiment. Too small is hard to pipette accurately, too large means the surplus is either wasted or refrozen, which defeats the point.
  • •Use sterile low-binding tubes. A peptide at low concentration can lose a meaningful fraction of itself to the wall of an ordinary polypropylene tube.
  • •Label each aliquot with sequence, concentration and date, and store at -20C or -80C depending on the peptide.

Summary

A peptide in solution degrades a little every time it is frozen and thawed. Ice crystals shear the molecule, the buffer salts crystallise at different rates so the pH moves, and the peptide concentrates at the edge of the forming ice. Do that ten times to one vial and the tenth experiment is not using the same material as the first.

Aliquoting is the fix, and it is simply this: reconstitute once, divide into single-use portions, freeze them separately, and thaw each one exactly once. The portion size should match one experiment, the tubes should be sterile and low-binding, and each should carry the sequence, concentration and date.

Some custom-synthesis suppliers will do the dividing before shipping. Volta does not; its catalogue peptides arrive as lyophilised bulk vials, so this is a bench procedure rather than something to tick on an order form.

The Freeze-Thaw Problem

Peptide researchers often face a common challenge: maintaining the stability and activity of their compounds after delivery. Repeated freeze-thaw cycles can degrade peptide structure, leading to inconsistent results and wasted material. Pre-aliquoting addresses this by dividing a peptide into single-use portions before it is frozen, either as a service offered by some custom-synthesis suppliers or as the first thing a laboratory does with a bulk vial.

What Is Pre-Aliquoting for Peptides?

Pre-aliquoting is a service offered during custom peptide synthesis that prepares your peptide in individual, measured portions before shipment. Instead of receiving a single bulk vial that requires manual division, researchers receive multiple aliquots, each containing the exact amount needed for a single experiment. This service is available for custom synthesis of standard peptides, peptide pools, and peptide libraries.

By specifying your preference and the desired number of aliquots in the order form, the manufacturer handles the entire process. The result is a set of precisely aliquoted peptides tailored to your research needs, delivered ready for immediate use.

Key Benefits of Pre-Aliquoting

Time-Saving

One of the most immediate advantages is the elimination of manual aliquoting upon receipt. Researchers no longer need to spend time measuring, diluting, and dividing bulk peptide solutions. The ready-to-go aliquots can be used directly in experiments, freeing up valuable laboratory time for other tasks.

Enhanced Stability

Pre-aliquoting minimizes the number of freeze-thaw cycles each peptide undergoes. Every time a peptide solution is frozen and thawed, there is a risk of degradation due to ice crystal formation, pH shifts, or concentration changes. By providing single-use aliquots, the integrity and activity of the peptides are maintained over time. This is especially important for sensitive peptides that are prone to aggregation or loss of bioactivity.

How the Service Works

To take advantage of pre-aliquoting, researchers simply specify their preference and the desired number of aliquots in the order form. The manufacturer then handles the aliquoting process during synthesis, ensuring each portion contains the correct volume and concentration. The aliquots are typically provided in sterile, low-binding tubes to minimize adsorption and contamination.

This service is integrated with custom synthesis orders, meaning it is not available for off-the-shelf peptides. It is designed for researchers who require consistent, reproducible quantities across multiple experiments or who work with large peptide libraries where manual aliquoting would be impractical.

Practical Considerations for Researchers

When ordering custom peptides with pre-aliquoting, consider the following:

  • Number of aliquots: Determine how many individual portions you need based on your experimental design. Overestimating can lead to waste, while underestimating may require additional orders.
  • Volume per aliquot: Ensure the volume is appropriate for your assay. Too small a volume may be difficult to handle, while too large may not be used in a single experiment.
  • Storage conditions: Pre-aliquoted peptides should be stored at the recommended temperature, typically -20°C or -80°C, depending on the peptide. Avoid repeated thawing of any single aliquot.

For researchers looking to improve their peptide handling, using a reconstitution calculator can help determine the correct solvent volume for each aliquot. Additionally, a stability calculator can provide guidance on storage duration and conditions.

Pre-Aliquoting vs. Bulk Storage

Bulk storage of peptides in a single vial is common but carries risks. Each time the vial is opened and thawed, the entire batch is exposed to moisture, air, and temperature fluctuations. Over time, this can lead to hydrolysis, oxidation, or microbial contamination. Pre-aliquoting eliminates these risks by providing a sealed, single-use container for each experiment.

For researchers who work with multiple peptides or large libraries, pre-aliquoting also simplifies inventory management. Each aliquot is labeled with the peptide sequence, concentration, and date, reducing the chance of mix-ups or misidentification.

Conclusion

Pre-aliquoting is a practical service that enhances the convenience and stability of peptide solutions. By minimizing freeze-thaw cycles and eliminating manual handling, it helps maintain peptide integrity and saves researchers time. This service is available for custom synthesis of standard peptides, peptide pools, and peptide libraries. For researchers seeking reliable, high-quality peptide solutions, pre-aliquoting offers a streamlined workflow and consistent experimental results.

Volta supplies catalogue peptides as lyophilised bulk vials and does not offer pre-aliquoting or custom synthesis, so on a Volta vial this is a bench procedure rather than an order option. The peptide aliquot calculator works out the split.

Frequently Asked Questions

Q: What types of peptides can be pre-aliquoted? A: Pre-aliquoting is available for custom synthesis of standard peptides, peptide pools, and peptide libraries. It is not typically offered for off-the-shelf or stock peptides.

Q: How do I specify the number of aliquots I need? A: You can specify your preference and the desired number of aliquots in the order form during the custom synthesis process. The manufacturer will handle the rest.

Q: Does pre-aliquoting affect the peptide's stability? A: Yes, positively. Pre-aliquoting minimizes freeze-thaw cycles, which helps maintain the integrity and activity of the peptides over time.

Q: Can I request different volumes for each aliquot? A: Typically, all aliquots in a single order are the same volume. If you need different volumes, you may need to place separate orders or contact the manufacturer for custom arrangements.

Q: How should I store pre-aliquoted peptides? A: Store them at the recommended temperature, usually -20°C or -80°C, and avoid thawing any aliquot more than once.

Research Use Only. This article is provided for informational and educational purposes only. The compounds and topics discussed are intended solely for laboratory and scientific research. This content does not constitute medical advice, and Volta Peptides does not endorse or promote human consumption of any research compound.

About the author

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Marcus Hopkin, PhD, is Director of Research and Development at Volta Peptides. He has more than 12 years of analytical chemistry experience, including direct laboratory work in peptide synthesis, characterization, purity testing and stability assessment. His doctoral research at the University of Michigan examined novel peptide structures in the human proteome and their potential significance for therapeutic-peptide research. Before joining Volta Peptides he held research and development roles at Amgen and Eli Lilly and Company, and served as a lecturer at the University of Michigan.

Marcus wrote this article, last reviewed September 15, 2026. It is in-house scientific writing by a named member of staff and is not peer review, independent third-party review or medical advice.

Disclosure. Marcus Hopkin is an employee of Volta Peptides and serves as its Director of Research and Development. Volta Peptides sells research compounds related to subjects discussed in the content he writes and reviews. His reviews are internal scientific and technical review and must not be described as independent third-party review, peer review or medical review.

More from the Blog

Science

What Is KPV Peptide? How It Works, What Research Shows, Legal Status, Safety and FDA's Recent Review

KPV is cut from alpha-MSH but does not act like it at the melanocortin receptors. What the cell and animal research measured, what the FDA concluded in July 2026, what the October 2026 HHS policy does and does not change, and where KPV stands in Canada and the US.

Nov 10
Science

What Are Targeting Peptides?

A targeting peptide is a short chain of 5 to 30 amino acids that recognises one receptor or tissue marker and acts as an address label for whatever is attached to it. This covers how the binding works, how a peptide is conjugated to a drug or nanoparticle, how cyclisation and D-amino acid substitution raise affinity and stability, and how display screening finds the sequences in the first place.

May 12
Science

Humanin: A Mitochondrially Encoded Peptide, Its Sequence and Receptor Signalling

Humanin is a 24-residue peptide encoded by the mitochondrial genome rather than the nuclear one. Its sequence and formula, the receptor complex and signalling pathways it is reported to engage in cell culture, the S14G analogue, and why its literature needs careful reading.

Jul 8
Science

BPC-157 10mg: Sequence, Analytical Identity and the Shape of the Literature

BPC-157 is a 15-residue synthetic peptide with no cysteine, methionine or tryptophan. Its sequence and registry data, what HPLC and mass spectrometry confirm on a lot, and why its published literature has to be read with its study design in view.

Jul 9
Guides

Where to Buy Peptides in Canada Online: The Ultimate Guide (2027 Edition)

A checkable procedure for evaluating any Canadian peptide supplier: the legal position under Health Canada, what actually happens to a cross-border parcel, how to read a Certificate of Analysis line by line, and the red flags that separate a real supplier from a dropshipper.

Aug 18
Science

What Is Ipamorelin? The Ghrelin-Receptor Peptide, Its One Human Trial, and Its Canadian Status

Ipamorelin is filed beside sermorelin and tesamorelin as though all three did the same thing. It acts at a different receptor, its one published efficacy trial missed its endpoint, and Health Canada named it in April 2026 among unauthorized injectable peptides.

Nov 11

Your Cart

Your cart is empty

Browse our catalog to add research compounds.